Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

U007 - Natural Compounds in Addressing Common Dermatologic Problems

Friday, February 16; 7:30 AM - 8:30 AM

Learning Objectives

Following this course, the attendee should be able to:

  • Formulate a treatment plan for several common dermatologic diseases that includes integrative therapies.
  • Summarize key takeaways on nutrition and skin health.

Description

Integrative dermatology is a growing field. This session will highlight the role for botanicals, herbs and nutrition, in common dermatologic illnesses including hair loss, acne/rosacea, eczema, and other inflammatory dermatoses.

Disclosures

  • Baldwin, Hilary E., MD: Allergan, Inc. – A(H); Bayer – SP(NC); Dermira – I(Grants/Research Funding); Galderma Laboratories, L.P. – SP(H); Novan – I(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – SP(H); Valeant Pharmaceuticals International – SP(H);
  • Goldberg, Matthew S, MD: no financial relationships exist with commercial interests.
  • Lio, Peter A., MD: AbbVie – C(Fees); Altus Labs – A(SO); Anacor Pharmaceuticals, Inc. – A(H); AOBiome, LLC – I(Grants/Research Funding); Dermavant Sciences – A(H); DermTap, Inc. – A(SO); DermVeda – A(SO); Eli Lilly and Company – C(Fees); Exeltis – C(Fees); Ferndale Laboratories, Inc. – SP(H); Franklin BioScience – C(SO); Galderma Laboratories, L.P. – SP(Fees); Galderma Laboratories, LP – C(Fees); gpower, inc. – A(H); Heel (Biologische Heilmittel Heel GmbH) – C(Fees); IntraDerm Pharmaceuticals – A(H); Johnson & Johnson Consumer Products Company – A(H), C(Fees), SP(Fees); Kiniksa Pharmaceuticals, Ltd. – C(H); L'Oreal USA Inc. – C(H); La Fondation pour la Dermatite Atopique (Foundation for Atopic Dermatitis – I(Grants/Research Funding); La Roche-Posay Laboratorie Pharmaceutique – SP(H); Menlo Therapeutics – A(H); Micreos Human Health B.V. – A(SO); Mission – Speaker/Faculty Education(H); Modernizing Medicine – A(NC), SH(SO); National Eczema Association – A(NC); Odeza LLC – C(SO); Pfizer Inc. – SP(H); Pierre Fabre Dermatologie – SP(H); Realm Therapeutics – A(H); Regeneron – A(Fees), SP(Fees); Sanofi US Services – A(H); Syncere Skin Systems – A(SO); Theraplex – C(Fees); UCB – A(H); Unilever – C(Fees); Valeant Pharmaceuticals International – C(Fees); Valeant Pharmaceuticals North America LLC – SP(H);
  • Rogers, Nicole Elaine, MD: Johnson & Johnson Consumer Products Company – C(Fees); ParaPRO LLC – SP(H); Redken – C(Fees); Regimen MD – SH(NC);
  • Rupani, Reena N., MD: Nutrafol – SP(H);
Schedule
Friday, February 16
7:30 AM
Dr. Rupani / CLINICAL PEARLS-- MY 3 FAVORITE HERBS
7:40 AM
Dr. Lio / ATOPIC DERMATITIS
7:50 AM
Dr. Rogers / HAIR LOSS
8:00 AM
Dr. Baldwin / ACNE
8:10 AM
Dr. Goldberg / GLUTEN AND THE SKIN
8:20 AM
All faculty / Q&A
Event Details
  • Date
    Friday, February 16
  • Time
    7:30 AM - 8:30 AM
  • Location
    Room 5B
  • CME Credits
    1.00
  • Type
Directors/Co-Directors
  • Reena N. Rupani, MD, FAAD
Speakers
  • Hilary E. Baldwin, MD, FAAD
  • Matthew S Goldberg, MD, FAAD - Handout
  • Nicole Elaine Rogers, MD, FAAD - Handout
  • Peter A. Lio, MD, FAAD